Holders — by stockHoldings — by fund

Foresite Capital Management IV, LLC

Everything this manager disclosed owning in US-listed stocks — its complete Form 13F portfolio · as of 2026-06-30 · filed with the SEC up to 45 days after quarter end · CIK 0001704132

$290.2M

disclosed book value

positions

57%

largest position share

Positions, as of 2026-06-30

top 6 of 6 · 13F covers long US-listed positions only — cash, bonds, private and foreign stakes are not disclosed · PUT/CALL tags = options positions (share-equivalents), not shares held

#	Issuer	Shares	Value	% of book
1	Pharvaris N.V.	4.8M	$165.2M	57%
2	CYTKCYTOKINETICS INC	714,695	$60.9M	21%
3	EIKNEikon Therapeutics, Inc.	1.9M	$25.4M	8.7%
4	RLAYRelay Therapeutics, Inc.	1.3M	$23.4M	8.1%
5	XENEXenon Pharmaceuticals Inc.	160,000	$9.7M	3.3%
6	CRNXCrinetics Pharmaceuticals, Inc.	150,000	$5.6M	1.9%

Source: SEC Form 13F-HR, reporting period 2026-06-30. Values are the manager's filed June-30-style quarter-end marks, not live prices. Research, not investment advice.